Abstract：
Narcotic consumption in the workers\' compensation population contributes to prolonged case duration, worse clinical outcomes, and opioid dependence. In 2016, the CDC provided recommendations guiding clinicians on prescribing opioids to adult patients with chronic pain. The objective of our study was to evaluate a cause-and-effect relationship between narcotic consumption and worker compensation claim length before and following guideline revision.
An administration database was retrospectively queried to identify patients evaluated for spine-related workers\' compensation claimants from 2011 to 2021. Data was recorded for age, sex, BMI, case length, narcotic usage, and injury location. Cases were grouped together by exam date before (2011-2016) and after (2017-2021) the 2016 CDC opioid guideline revision.
Six hundred twenty-five patients were evaluated. Males composed 58% of the study population. From 2011 to 2016, narcotic consumption was reported in 54% of subjects versus no narcotic consumption in 46% of subjects (135 cases). From 2017 to 2021, narcotic consumption decreased to 37% (P = 0.00298). Prior to the guideline revision, mean case length was 635 days. Following CDC guideline revision, there was a significant decline in mean case length duration to 438 days (31% reduction) (P = 0.000868).
This study demonstrates that following revised opioid prescription recommendations by the CDC in 2016, there was a statistically significant decline in opioid consumption and workers\' compensation case length duration. Opioid use may influence prolonged worker disability and delayed return to work.
An administration database was retrospectively queried to identify patients evaluated for spine-related workers\' compensation claimants from 2011 to 2021. Data was recorded for age, sex, BMI, case length, narcotic usage, and injury location. Cases were grouped together by exam date before (2011-2016) and after (2017-2021) the 2016 CDC opioid guideline revision.
Six hundred twenty-five patients were evaluated. Males composed 58% of the study population. From 2011 to 2016, narcotic consumption was reported in 54% of subjects versus no narcotic consumption in 46% of subjects (135 cases). From 2017 to 2021, narcotic consumption decreased to 37% (P = 0.00298). Prior to the guideline revision, mean case length was 635 days. Following CDC guideline revision, there was a significant decline in mean case length duration to 438 days (31% reduction) (P = 0.000868).
This study demonstrates that following revised opioid prescription recommendations by the CDC in 2016, there was a statistically significant decline in opioid consumption and workers\' compensation case length duration. Opioid use may influence prolonged worker disability and delayed return to work.
摘要：
背景：工人补偿人群中的麻醉品消费导致案件持续时间延长，更差的临床结果，和阿片类药物依赖。2016年，疾病预防控制中心提供了指导临床医生为患有慢性疼痛的成年患者开具阿片类药物的建议。我们研究的目的是评估指南修订之前和之后的麻醉品消费与工人赔偿要求长度之间的因果关系。
方法：回顾性查询了一个管理数据库，以确定从2011年到2021年被评估为脊柱相关工人索赔的患者。数据记录了年龄，性别,BMI,案例长度,麻醉剂的使用，和受伤地点。病例在2016年CDC阿片类药物指南修订之前（2011-2016年）和之后（2017-2021年）按检查日期分组。
结果：对六百二十五名患者进行了评估。男性占研究人群的58％。从2011年到2016年，有54％的受试者报告了麻醉品消费，而46％的受试者则没有麻醉品消费（135例）。从2017年到2021年，麻醉药品消费量下降到37%（P=0.00298）。在修订准则之前，平均病例长度为635天.根据CDC指南修订，平均病例长度持续时间显著减少至438天(减少31%)(P=0.000868).
结论：这项研究表明，根据CDC在2016年修订的阿片类药物处方建议，阿片类药物消费量和工人补偿病例持续时间在统计上显着下降。阿片类药物的使用可能会影响长期的工人残疾和延迟返回工作。
方法：回顾性查询了一个管理数据库，以确定从2011年到2021年被评估为脊柱相关工人索赔的患者。数据记录了年龄，性别,BMI,案例长度,麻醉剂的使用，和受伤地点。病例在2016年CDC阿片类药物指南修订之前（2011-2016年）和之后（2017-2021年）按检查日期分组。
结果：对六百二十五名患者进行了评估。男性占研究人群的58％。从2011年到2016年，有54％的受试者报告了麻醉品消费，而46％的受试者则没有麻醉品消费（135例）。从2017年到2021年，麻醉药品消费量下降到37%（P=0.00298）。在修订准则之前，平均病例长度为635天.根据CDC指南修订，平均病例长度持续时间显著减少至438天(减少31%)(P=0.000868).
结论：这项研究表明，根据CDC在2016年修订的阿片类药物处方建议，阿片类药物消费量和工人补偿病例持续时间在统计上显着下降。阿片类药物的使用可能会影响长期的工人残疾和延迟返回工作。
